Darya-Varia Laboratoria Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Darya-Varia Laboratoria Tbk PT with three other
pharmaceutical manufacturers in Asia:
Shanghai Fudan Forward S&T Co Ltd
sales of 735.73 million Chinese Renmimbi [US$106.97 million]
of which 64%
Daehwa Pharmaceutical Company Limited
of South Korea
(122.20 billion Korean Won [US$108.88 million]
Searle Co Ltd
based in Pakistan
(13.31 billion Pakistan Rupees [US$108.61 million]
During the year ended December of 2017, sales at
Darya-Varia Laboratoria Tbk PT were 1.58 trillion Indonesian Rupiahs (US$107.93 million).
increase of 8.6%
versus 2016, when the company's sales were 1.45 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Darya-Varia Laboratoria Tbk PT
(and since 2012, sales have increased a total of 45%).
Sales of Consumer Health saw an increase
14.3% in 2017, from
652.63 billion Indonesian Rupiahs to 745.92 billion Indonesian Rupiahs.
Not all segments of Darya-Varia Laboratoria Tbk PT experienced an increase in sales in 2017:
sales of Toll Manufacturing fell 8.4% to 292.43 billion Indonesian Rupiahs.